Composite vascular graft including bioactive agent coating and biodegradable sheath

• US 20060009839A1
• Filed: 07/12/2004
• Published: 01/12/2006
• Est. Priority Date: 07/12/2004
• Status: Abandoned Application

• Current Assignee: Lifeshield Sciences LLC (Acacia Research Corporation)
• Original Assignee: Scimed Life Systems Incorporated (Boston Scientific Corporation)
• Inventors: Tan, Sharon Mi Lyn
• Application Number:
  US10/889,432
• Publication Number:
  US 20060009839A1
• Time in Patent Office: Days
• US Class Current: 623/1.380
• CPC Class Codes: A61F 2/06 Blood vessels
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2002/072 Encapsulated stents, e.g. wire or whole stent embedded in lining
• CPC Class Codes: A61F 2210/0004 bioabsorbable
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body

Abstract

A composite vascular graft incorporates bioactive agents to deliver therapeutic materials and/or inhibit or reduce bacterial growth during and following the introduction of the graft to the implantation site in a vascular system. A composite vascular graft includes a porous tubular graft member. One or more biodegradable, bioactive agent coating layers are disposed over the graft member, the coating layer including at least one bioactive agent. A biodegradable sheath is disposed over the coating layer. The sheath has a rigidity greater than the flexible tubular graft member and is biodegradable to expose the coating layer so as to re-establish the flexibility of the tubular graft member.

Claims

1. A composite vascular graft comprising:

a porous, flexible tubular graft member;

a biodegradable, bioactive agent coating layer disposed over said graft member;

said coating layer including at least one bioactive agent; and

a biodegradable sheath disposed over said coating layer, said sheath having a rigidity greater than said flexible tubular graft member; and

being biodegradable to expose said coating layer so as to re-establish the flexibility of said tubular graft member.

2. The vascular graft of claim 1, wherein said bioactive agent is an antimicrobial agent.

3. The vascular graft of claim 2, wherein said antimicrobial agent is an antibiotic or antiseptic agent.

4. The vascular graft of claim 3, wherein said antibiotic agent is selected from the group consisting of ciprofloxacin, vancomycin, minocycline, rifampin and combinations thereof.

5. The vascular graft of claim 3, wherein the antiseptic agent is selected from the group consisting of a silver agent, chlorhexidine, triclosan, iodine, benzalkonium chloride, and combinations thereof.

6. The vascular graft of claim 1, wherein said porous tubular graft member comprises ePTFE material.

7. The vascular graft of claim 1, wherein said porous tubular graft member comprises a textile material.

8. The vascular graft of claim 7, wherein said textile material comprises a construction selected from the group consisting of weaves, braids, filament windings, spun fibers and combinations thereof.

9. The vascular graft of claim 7, wherein said textile material is formed from synthetic yarns selected from the group consisting of polyesters, PET polyesters, polypropylenes, polyethylenes, polyurethanes, polytetrafluoroethylenes and combinations thereof.

10. The vascular graft of claim 1, wherein the biodegradable, bioactive agent coating layer is comprised of a natural, modified natural or synthetic polymer.

11. The vascular graft of claim 10, wherein said polymer is selected from the group consisting of fibrin, collagen, celluloses, gelatin, vitronectin, fibronectin, laminin, reconstituted basement membrane matrices, starches, dextrans, alginates, hyaluronic acid, poly(lactic acid), poly(glycolic acid), polypeptides, glycosaminoglycans, their derivatives and mixtures thereof.

12. The vascular graft of claim 10, wherein said polymer is selected from the group consisting of polydioxanoes, polyoxalates, poly(α

-esters), polyanhydrides, polyacetates, polycaprolactones, poly(orthoesters), polyamino acids, polyamides and mixtures and copolymers thereof.

13. The vascular graft of claim 10, wherein said polymer is selected from the group consisting of stereopolymers of L- and D-lactic acid, copolymers of bis(p-carboxyphenoxy) propane acid and sebacic acid, sebacic acid copolymers, copolymers of caprolactone, poly(lactic acid)/poly(glycolic acid)/polyethyleneglycol copolymers, copolymers of polyurethane and (poly(lactic acid), copolymers of polyurethane and poly(lactic acid), copolymers of α

-amino acids, copolymers of α

-amino acids and caproic acid, copolymers of α

-benzyl glutamate and polyethylene glycol, copolymers of succinate and poly(glycols), polyphosphazene, polyhydroxy-alkanoates and mixtures thereof.

14. The vascular graft of claim 1, wherein said bioactive agent coating is applied to said tubular graft member.

15. The vascular graft of claim 1, wherein said bioactive agent coating is applied in multiple layers.

16. The vascular graft of claim 1, wherein the biodegradable sheath has a tubular or sheet-like configuration for disposal over said bioactive agent coating layer.

17. The vascular graft of claim 1, wherein the biodegradable sheath is comprised of a material selected from the group consisting of polylactides, polyanhydrides, polyvinyl alcohol, polyvinylpyrolidone, polyglycols, gelatin derivatives, and combinations thereof.

18. The vascular graft of claim 1, wherein the biodegradable sheath includes at least one antimicrobial agent.

19. A method of making a vascular graft for delivery of an antimicrobial agent associated therewith to a site of implantation of said graft, said method comprising the steps of:

providing a porous, flexible tubular graft member;

applying a biodegradable coating material to said porous tubular graft member so as to form one or more overlying biodegradable, bioactive agent coating layers, said biodegradable coating material having at least one bioactive agent incorporated therein; and

disposing a biodegradable sheath over said one or more overlying coating layers.

20. The method of claim 19, wherein the disposing step includes providing the sheath in a tubular configuration and placing said sheath over the one or more coating layers overlying said graft member.

21. The method of claim 19, wherein the disposing step includes providing the sheath in a sheet-like configuration and wrapping the sheet over the one or more coating layers overlying said graft member.

22. The method of claim 19, further comprising the step of interposing a prosthetic stent between said tubular graft member and said bioactive agent coating layer.

23. The method of claim 19, further comprising the step of incorporating said bioactive agent into said biodegradable coating material.

24. The method of claim 19, wherein said bioactive agent is an antimicrobial agent selected from the group consisting of antiseptic agents, antibiotic agents, and combinations thereof.